Ingredient in common cough medicine may aid diabetes treatment
the ONA take:
An ingredient found in common cough medicine may be able to aid in the treatment of patients with type 2 diabetes, according to a study published in Nature Medicine.
Researchers examined the effects of dextromethorphan, an active ingredient in cough suppressants, in order to build on prior research which showed that it had potential impact on receptor cells in the pancreas. Initially they hypothesized that the compound would actually worsen insulin production.
Instead, the team found that the ingredient caused the receptor cells to boost insulin production in the pancreas.
They tested the effect with a single-dose trial in 20 male patients with diabetes and found that the men “showed enhanced serum insulin concentrations and glucose tolerance.”
Findings, however, are still preliminary, and the researchers advise against diabetics self-medicating with cough medicine. Future testing was encouraged by the team.
An ingredient found in common cough medicine may be able to aid in the treatment of patients with type 2 diabetes.
Sign Up for Free e-newsletters
- Hodgkin Lymphoma Survivorship Marked by Periods of Actionable Distress
- Medication, Vaccination Uptake Improved by Involving Pharmacists in Elder Cancer Care
- Dose-Escalation Mitigates Risk of Grade 3/4 Adverse Events With Ruxolitinib for Myelofibrosis
- Stem Cell Transplantation Superior to Chemotherapy for Relapsed/Refractory DLBCL, Follicular Lymphoma
- Study Reveals Relationship of Sleep Duration, Diabetes Risk in Cancer Survivors
- Navigating Prostate Cancer: A Patient's Experience From Diagnosis to Survivor
- Cell Phones and Cancer Risk (Fact Sheet)
- How Likely Are Oncologists to Refer for Palliative Care? Depends on Their Age
- Use of Corticosteroids With PD-1 or PD-L1 Inhibitors Associated With Poorer Outcomes in NSCLC
- Chemoimmunotherapy Increases Survival in Triple-Negative Breast Cancer
- Risk for Colon Cancer, Osteogenic Sarcoma Higher With Presence of Diamond-Blackfan Anemia
- G-CSF Support Increases Overall Survival, But Risk of Secondary Malignancies Also Higher
- Report From Childhood Cancer Survivor Study Identifies Long-Term Risks for VTE
- The Effect of Intravenous Hydration Strategy on Plasma Methotrexate Clearance During Intravenous High-dose Methotrexate Administration in Pediatric Oncology Patients
- Outcomes Worse for Minimally Invasive Hysterectomy vs Open Surgery
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|